Belimumab - AstraZeneca/GSK
At a glance
- Drug Originator Cambridge Antibody Technology; Human Genome Sciences
- Drug Class Anti-inflammatories; Antineoplastics; Antirheumatics; Immunotherapies; Monoclonal antibodies; Skin disorder therapies; Urologics
- Mechanism of Action B cell activating factor inhibitors
- USA Patent Applicants HUMAN GENOME SCIENCES INC.; GLAXOSMITHKLINE LLC
- USA Patents 88
- BLAs 2
- International Patents 1,245
Disclaimer